Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis

Saved in:
Bibliographic Details
Published in:Arthritis and rheumatism 2006-04, Vol.55 (2), p.333-337
Main Authors: Giles, Jon T., Bartlett, Susan J., Gelber, Allan C., Nanda, Shikha, Fontaine, Kevin, Ruffing, Victoria, Bathon, Joan M.
Format: Article
Language:English
Subjects:
Adalimumab
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized
Antirheumatic Agents - adverse effects
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - surgery
Bacterial Infections - etiology
Biological and medical sciences
Diseases of the osteoarticular system
Etanercept
Female
Humans
Immunoglobulin G - adverse effects
Inflammatory joint diseases
Infliximab
Male
Medical sciences
Middle Aged
Orthopedic Procedures
Postoperative Complications - etiology
Receptors, Tumor Necrosis Factor
Risk Factors
Severity of Illness Index
Tumor Necrosis Factors - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0004-3591
0893-7524
1529-0131
1529-0123
DOI:10.1002/art.21841